HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Remission of primary cutaneous anaplastic large cell lymphoma after a brief course of brentuximab vedotin.

AuthorsAmrita Desai, Gladys H Telang, Adam J Olszewski
JournalAnnals of hematology (Ann Hematol) Vol. 92 Issue 4 Pg. 567-8 (Apr 2013) ISSN: 1432-0584 [Electronic] Germany
PMID23086510 (Publication Type: Case Reports, Letter)
Chemical References
  • Antineoplastic Agents
  • Immunoconjugates
  • Brentuximab Vedotin
Topics
  • Aged
  • Antineoplastic Agents (administration & dosage, adverse effects)
  • Brentuximab Vedotin
  • Drug Administration Schedule
  • Humans
  • Immunoconjugates (administration & dosage, adverse effects)
  • Lymphoma, Primary Cutaneous Anaplastic Large Cell (drug therapy)
  • Male
  • Remission Induction (methods)
  • Skin Neoplasms (drug therapy)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: